Table 1. Characteristics of Rotarix and RotaTeq vaccines for the prevention of rotavirus associated diarrhoea.

	Rotarix	Source	RotaTeq	Source
Manufacture	Glaxo Smith Kline	[11]	Merck	[12]
Doses	2 doses	[11]	3 doses	[12]
Vaccine virus	G1P(8)	[11]	G1,G2,G3,G4,P1A(8)	[12]
Concentration	106 CCID­	[11]	2.2×106 G1, 2.8×106 G2, 2.2×106 G3, 2.0×106 G4, 2.3×106 P1A(8)	[12]
Cross potection	G1, G3, G4, G9	[11]	G1,G2,G3,G4	[12]
Administration	Oral	[11]	Oral	[12]
Timing of doses	6–24 weeks	[11]	6–32 weeks	[12]
Interval between doses	Minimal 4 weeks	[11]	4 to 10 weeks	[12]
Store temp vial	2–8 degrees celcius	[11]	2–8 degrees celcius	[12]
Use within	24 hours	[12]	As soon as possible	[12]
Package size vial	17.1cm3 per dose (full course: 34.2cm3)	[38]	46.3cm3 per dose (full course: 138.9cm3)	[38]
Vaccine Vial Monitor technology	Yes	[38]	No	[38]
Price	$2.5 per dose, $5 full course	[25]	$3.5 per dose, $10.5 full course	[26]
Shelf life	24 months	[11]	24 months	[12]
Adverse events	Low	[11]	Low	[12]
Thermostability	Proven	[37]	Unproven